About Rosacea
Rosacea is a chronic skin disease that generally affects the white population. The exact cause of rosacea remains unknown. As a result, there is no specific cure for the disease. Research is leading to the introduction of methods to treat the condition by minimizing its symptoms.
Technavio’s analysts forecast the Global Rosacea Treatment Market to grow at a CAGR of 2.46% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the rosacea treatment market. To calculate the market size, the report considers the revenue generated by sales of topical and oral rosacea treatment products across the globe.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, rosacea treatment market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• ALLERGAN
• Bayer
• Bausch Health
• Nestlé
• Sol-Gel Technologies
Market driver
• Growing rate of incidence of rosacea
• For a full, detailed list, view our report
Market challenge
• High competition from generic drugs
• For a full, detailed list, view our report
Market trend
• Use of topical treatment
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: PIPELINE LANDSCAPE
• Drugs under development
PART 08: MARKET SEGMENTATION BY APPLICATION
• Segmentation by application
• Comparison by application
• Topical – Market size and forecast 2017-2022
• Oral – Market size and forecast 2017-2022
• Market opportunity by application
PART 09: CUSTOMER LANDSCAPE
PART 10: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas – Market size and forecast 2017-2022
• EMEA – Market size and forecast 2017-2022
• APAC – Market size and forecast 2017-2022
• Key leading countries
• Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 13: MARKET TRENDS
• Use of topical treatment
• Shift toward combination products
• Technological advances
PART 14: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 15: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• ALLERGAN
• Bayer
• Bausch Health
• Nestlé
• Sol-Gel Technologies
PART 16: APPENDIX
• List of abbreviations
Exhibit 01: Parent market
Exhibit 02: Global dermatology market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2017
Exhibit 18: Rosacea pipeline landscape
Exhibit 19: Molecules in pipeline
Exhibit 20: Application – Market share 2017-2022 (%)
Exhibit 21: Comparison by application
Exhibit 22: Topical – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Topical – Year-over-year growth 2018-2022 (%)
Exhibit 24: Oral – Market size and forecast 2017-2022 ($ mn)
Exhibit 25: Oral – Year-over-year growth 2018-2022 (%)
Exhibit 26: Market opportunity by application
Exhibit 27: Customer landscape
Exhibit 28: Global – Market share by geography 2017-2022 (%)
Exhibit 29: Regional comparison
Exhibit 30: Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 31: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 32: EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 33: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 34: APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 35: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Vendor landscape
Exhibit 39: Landscape disruption
Exhibit 40: Vendors covered
Exhibit 41: Vendor classification
Exhibit 42: Market positioning of vendors
Exhibit 43: ALLERGAN – Overview
Exhibit 44: ALLERGAN – Business segments
Exhibit 45: ALLERGAN – Organizational developments
Exhibit 46: ALLERGAN – Geographic focus
Exhibit 47: ALLERGAN – Segment focus
Exhibit 48: ALLERGAN – Key offerings
Exhibit 49: ALLERGAN – Key customers
Exhibit 50: Bayer – Overview
Exhibit 51: Bayer – Business segments
Exhibit 52: Bayer – Organizational development
Exhibit 53: Bayer – Geographic focus
Exhibit 54: Bayer – Segment focus
Exhibit 55: Bayer – Key offerings
Exhibit 56: Bayer – Key customers
Exhibit 57: Bausch Health – Overview
Exhibit 58: Bausch Health – Business segments
Exhibit 59: Bausch Health – Organizational developments
Exhibit 60: Bausch Health – Geographic focus
Exhibit 61: Bausch Health – Segment focus
Exhibit 62: Bausch Health – Key offerings
Exhibit 63: Bausch Health – Key customers
Exhibit 64: Nestlé – Overview
Exhibit 65: Nestlé – Business segments
Exhibit 66: Nestlé – Organizational developments
Exhibit 67: Nestlé – Geographic focus
Exhibit 68: Nestlé - Segment focus
Exhibit 69: Nestlé – Key offerings
Exhibit 70: Nestlé – Key customers
Exhibit 71: Sol-Gel Technologies – Overview
Exhibit 72: Sol-Gel Technologies – Business segments
Exhibit 73: Sol-Gel Technologies – Organizational developments
Exhibit 74: Sol-Gel Technologies – Segment focus
Exhibit 75: Sol-Gel Technologies – Key offerings
Exhibit 76: Sol-Gel Technologies – Key customers
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: PIPELINE LANDSCAPE
• Drugs under development
PART 08: MARKET SEGMENTATION BY APPLICATION
• Segmentation by application
• Comparison by application
• Topical – Market size and forecast 2017-2022
• Oral – Market size and forecast 2017-2022
• Market opportunity by application
PART 09: CUSTOMER LANDSCAPE
PART 10: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas – Market size and forecast 2017-2022
• EMEA – Market size and forecast 2017-2022
• APAC – Market size and forecast 2017-2022
• Key leading countries
• Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 13: MARKET TRENDS
• Use of topical treatment
• Shift toward combination products
• Technological advances
PART 14: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 15: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• ALLERGAN
• Bayer
• Bausch Health
• Nestlé
• Sol-Gel Technologies
PART 16: APPENDIX
• List of abbreviations
Exhibit 01: Parent market
Exhibit 02: Global dermatology market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2017
Exhibit 18: Rosacea pipeline landscape
Exhibit 19: Molecules in pipeline
Exhibit 20: Application – Market share 2017-2022 (%)
Exhibit 21: Comparison by application
Exhibit 22: Topical – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Topical – Year-over-year growth 2018-2022 (%)
Exhibit 24: Oral – Market size and forecast 2017-2022 ($ mn)
Exhibit 25: Oral – Year-over-year growth 2018-2022 (%)
Exhibit 26: Market opportunity by application
Exhibit 27: Customer landscape
Exhibit 28: Global – Market share by geography 2017-2022 (%)
Exhibit 29: Regional comparison
Exhibit 30: Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 31: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 32: EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 33: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 34: APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 35: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Vendor landscape
Exhibit 39: Landscape disruption
Exhibit 40: Vendors covered
Exhibit 41: Vendor classification
Exhibit 42: Market positioning of vendors
Exhibit 43: ALLERGAN – Overview
Exhibit 44: ALLERGAN – Business segments
Exhibit 45: ALLERGAN – Organizational developments
Exhibit 46: ALLERGAN – Geographic focus
Exhibit 47: ALLERGAN – Segment focus
Exhibit 48: ALLERGAN – Key offerings
Exhibit 49: ALLERGAN – Key customers
Exhibit 50: Bayer – Overview
Exhibit 51: Bayer – Business segments
Exhibit 52: Bayer – Organizational development
Exhibit 53: Bayer – Geographic focus
Exhibit 54: Bayer – Segment focus
Exhibit 55: Bayer – Key offerings
Exhibit 56: Bayer – Key customers
Exhibit 57: Bausch Health – Overview
Exhibit 58: Bausch Health – Business segments
Exhibit 59: Bausch Health – Organizational developments
Exhibit 60: Bausch Health – Geographic focus
Exhibit 61: Bausch Health – Segment focus
Exhibit 62: Bausch Health – Key offerings
Exhibit 63: Bausch Health – Key customers
Exhibit 64: Nestlé – Overview
Exhibit 65: Nestlé – Business segments
Exhibit 66: Nestlé – Organizational developments
Exhibit 67: Nestlé – Geographic focus
Exhibit 68: Nestlé - Segment focus
Exhibit 69: Nestlé – Key offerings
Exhibit 70: Nestlé – Key customers
Exhibit 71: Sol-Gel Technologies – Overview
Exhibit 72: Sol-Gel Technologies – Business segments
Exhibit 73: Sol-Gel Technologies – Organizational developments
Exhibit 74: Sol-Gel Technologies – Segment focus
Exhibit 75: Sol-Gel Technologies – Key offerings
Exhibit 76: Sol-Gel Technologies – Key customers
